chr22-26541524-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003595.5(TPST2):c.107C>T(p.Ala36Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,611,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003595.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TPST2 | NM_003595.5 | c.107C>T | p.Ala36Val | missense_variant | 3/7 | ENST00000338754.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TPST2 | ENST00000338754.9 | c.107C>T | p.Ala36Val | missense_variant | 3/7 | 1 | NM_003595.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000744 AC: 18AN: 242038Hom.: 0 AF XY: 0.0000984 AC XY: 13AN XY: 132098
GnomAD4 exome AF: 0.0000576 AC: 84AN: 1459308Hom.: 0 Cov.: 34 AF XY: 0.0000758 AC XY: 55AN XY: 725938
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.107C>T (p.A36V) alteration is located in exon 3 (coding exon 1) of the TPST2 gene. This alteration results from a C to T substitution at nucleotide position 107, causing the alanine (A) at amino acid position 36 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at